Renal Cell Cancer
Here below, you will find a list of all the latest content published on this website on the topic of Renal Cell Cancer. The content is published in chronological order. Find out more about our content categorisation.
-
« Previous
- 1
- 2
- ...
- 18
-
Next »
- Lymphocytes express receptor tyrosine kinases in patients with renal cell carcinoma and healthy donors
- 9-ING-41, a clinically relevant inhibitor of glycogen synthase kinase-3 (GSK-3), is active pre-clinically in human bladder and renal cell cancers
- Kidney cancer
- Treatment of clear cell RCC
- ESMO Academy 2018
- Diverse Delayed Skin Reactions To PD-1 Inhibitor Therapy Revealed
- Germline Mutations Prevalent In Advanced RCC Patients
- Sorafenib–Chemotherapy Tested For Metastatic Renal Collecting Duct Carcinoma
- Systemic treatment of advanced renal cancer
- Perspectives from ASCO 2018: Advances in metastatic RCC, the CARMENA study
- ESMO videos: Perspectives from ASCO 2018
- ASCO 2018: Sunitinib Alone Sufficient For RCC Patients With Limited Metastatic Burden
- Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
- ESMO E-Learning: Next Generation Drugs in Kidney Cancer
- Introduction
- Case presentation: Immunotherapy in kidney metastatic cancer: When?
- Metastatic renal cancer: evidence-based treatment
- First-Line Nivolumab Plus Ipilimumab Supported For Intermediate-, Poor-Risk Advanced RCC
- Early Avelumab Plus Axitinib Findings ‘Encouraging’ For Treatment-Naive Advanced RCC
- ESMO Videos on Genitourinary Cancers: Highlights from ASCO GU 2018
- ASCO GU: Highlights on Renal Cell Cancer: IMmotion151 and Other Combination Studies
- Axitinib–Pembrolizumab ‘Promising’ As Possible First-Line Combination For Advanced RCC
- Participant Clinical Case Discussion: Immunotherapy to the Rescue in Advanced RCC
- Advanced Urinary Cancer (Renal and Bladder)
- Cabozantinib ‘Good Treatment Option’ For RCC Bone Metastases
-
« Previous
- 1
- 2
- ...
- 18
-
Next »